SBBP Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs...

Stats
Dzisiejszy wolumen	684 683
Średni wolumen	316 352
Kapitalizacja rynkowa	0.00
EPS	$-0.0700 ( 2021-08-05 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.111 (5.55%)

Insider Trading

Date	Person	Action	Amount	type
2021-10-05	Cdk Associates, L.l.c.	Sell	8 060 682	Ordinary Shares, $0.01 par value
2021-10-05	Cdk Associates, L.l.c.	Sell	2 220 000	Ordinary Shares Warrant (right to buy)
2021-10-05	Wilhoit Scott L.	Sell	109 510	Ordinary Shares
2021-10-05	Wilhoit Scott L.	Sell	649 000	Stock Option (Right to Buy)
2021-10-05	Kollender Richard S	Sell	234 229	Ordinary Shares

INSIDER POWER
0.00
Last 99 transactions
Buy: 6 188 774 \| Sell: 17 044 650

Wolumen Korelacja

Długi: 0.22 (neutral)

Krótki: -0.76 (moderate negative)

Signal:(42.06) Neutral

Strongbridge Biopharma Korelacja

10 Najbardziej pozytywne korelacje
ATNX	0.904
FINW	0.898
ORRF	0.896
RAPT	0.895
CFV	0.894
REKR	0.891
COMM	0.89
VIEW	0.889
GMII	0.889
SABR	0.888

10 Najbardziej negatywne korelacje
DFH	-0.93
COUP	-0.912
ICON	-0.91
PCTI	-0.903
CRVL	-0.902
FEYE	-0.9
CVT	-0.899
TWNK	-0.894
CFMS	-0.891
BTF	-0.889

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Strongbridge Biopharma Korelacja - Waluta/Towar

-0.82
( strong negative )

-0.72
( moderate negative )

0.00
( neutral )

-0.67
( moderate negative )

0.52
( weak )

0.84
( strong )

Strongbridge Biopharma Finanse

Annual	2020
Przychody:	$30.73M
Zysk brutto:	$28.52M (92.80 %)
EPS:	$-0.780

FY	2020
Przychody:	$30.73M
Zysk brutto:	$28.52M (92.80 %)
EPS:	$-0.780

FY	2019
Przychody:	$21.71M
Zysk brutto:	$17.89M (82.40 %)
EPS:	$-0.910

FY	2018
Przychody:	$18.03M
Zysk brutto:	$14.04M (77.89 %)
EPS:	$0.690

Financial Reports:

No articles found.

Strongbridge Biopharma

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trials that for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania.